Drugs / YH1885L
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01750437 | Jan → Oct 2013 | gastroesophageal reflux disease | Yuhan Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YH1885L | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01750437 ↗ |
| Known as | Revaprazan | “Drug: YH1885L(Revaprazan)” NCT01750437 ↗ |